Driven by a team of Women technocrats with a cumulative experience of over 100 years in the fields of life sciences, Aristogene is amongst the first companies in the world to develop and commercialise bacteriophage products for treatment of infections in poultry and aquaculture. Aristogene has filed three patents for the products in aquaculture.
We are a biotech company based in Bangalore driven by Indian ethos and a global perspective. With over 2 decades of experience in manufacture of enzymes, biochemical for research companies and reagents for educational institutions, we have evolved to become a global leader in manufacturing of bacteriophage products for treatment of infections in livestock, poultry, aqua culture and agricultural sectors. We specialize in the realm of genomics and proteomics and have gone commercial with our bacteriphage products such as Vibrioshield, Elixir, Colishield, Salshield, VibZet and many more. These products have been tested extensively, tried and being used across poultry and aquaculture both for prophylaxis and for treating infections.
The need for bacteriophage products is necessitated by the fact that several countries have banned the use of antibiotics since over use of antibiotics is leading to AMR (antimicrobial resistance) problem. This is of great concern worldwide. Alternatives to antibiotics are the best way forward to make the society healthier. 'Antibiotic free' produce is a big welcome in the market too.
As we continue on our relentless pursuit of excellence, we hope to broaden our horizons and venture out into the areas of the unknown; delve deep into our research activities and emerge with products that suit mankind in a more harmless way. Aristogene will continue to invest its time and efforts with like minded companies and be involved in quality conscious R & D and sustainable development of newer Bacteriophage therapies.
